News
CNVVF
3.100
NaN%
--
RBC Capital Sticks to Its Buy Rating for ConvaTec (CTEC)
TipRanks · 12/18 07:16
UBS Sticks to Their Buy Rating for ConvaTec (CTEC)
TipRanks · 12/17 09:26
Morgan Stanley Remains a Buy on ConvaTec (CTEC)
TipRanks · 12/15 16:36
ConvaTec (CTEC) Receives a Buy from UBS
TipRanks · 12/11 10:05
ConvaTec Executes Share Buyback as Part of $300 Million Program
TipRanks · 12/03 07:18
Convatec Announces Updated Total Voting Rights
TipRanks · 12/01 11:04
ConvaTec Executes Share Buyback as Part of $300 Million Program
TipRanks · 12/01 07:26
ConvaTec Advances $300M Share Buyback with Recent Purchase
TipRanks · 11/28 07:17
ConvaTec Advances $300M Share Buyback Program
TipRanks · 11/27 07:18
ConvaTec Executes Share Buyback as Part of $300 Million Program
TipRanks · 11/26 07:19
ConvaTec Executes Share Buyback as Part of $300 Million Program
TipRanks · 11/25 07:18
ConvaTec Executes Strategic Share Buyback
TipRanks · 11/24 07:13
ConvaTec Executes Share Buyback as Part of $300 Million Program
TipRanks · 11/21 07:16
ConvaTec Advances Share Buyback Program with Significant Share Purchase
TipRanks · 11/20 07:20
ConvaTec Executes Share Buyback as Part of $300M Program
TipRanks · 11/19 07:17
ConvaTec (CTEC) Gets a Buy from J.P. Morgan
TipRanks · 11/15 03:25
ConvaTec (CTEC) Receives a Buy from Barclays
TipRanks · 11/14 07:35
Goldman Sachs Sticks to Their Buy Rating for ConvaTec (CTEC)
TipRanks · 11/14 07:05
Peel Hunt Keeps Their Buy Rating on ConvaTec (CTEC)
TipRanks · 11/13 16:56
ConvaTec’s Strong Organic Growth and Financial Stability Justify Buy Rating
TipRanks · 11/13 09:05
More
Webull provides a variety of real-time CNVVF stock news. You can receive the latest news about Convatec Group Plc through multiple platforms. This information may help you make smarter investment decisions.
About CNVVF
Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. Advanced Wound Care includes advanced dressings for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories, and personalized services for individuals with a stoma. Continence Care includes products and services for people with urinary continence issues related to spinal cord injuries and other causes. Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.